Clinical Trial Update: Fecal Microbial Transplantation in Combination With Immunotherapy in Melanoma Patients (MIMic) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating fecal microbiota transplantation in combination with immunotherapy for melanoma; the study is currently active but not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Melanoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING